SEFH offers new approaches to pharmaceutical care for HIV

Spanish Society of Hospital Pharmacy (SEFH) Yesterday the third meeting took place in webinar format SEFH Patient Schoolcalled Aging with HIVwhich discussed key topics such as fragility, polypharmacy, medication adherence and the critical role of the pharmacist in improving health through integrated care. The meeting was attended by: Diego Garcia (peer educator from Adhara Murcia), Joaquim Roqueta (Member of the CESIDA Executive Committee and President of the GAIS POSITIUS Association

), Ramon Morillo (pharmacist at HU de Valme Hospital, Seville)) And Robustillo Waters (Pharmacist at the HU de Valme Hospital in Seville and AFVIH-SEFH coordinator).

Robustillo Waters, session moderatorhighlighted the existence of different realities among people living with HIV older people with special needs covering various aspects, such as social, economic, psychological or pharmacotherapeutic areas. “At Hospitalria Pharmacy, we are going to do everything we can to adapt to this reality through the new approaches to pharmaceutical care that we are developing.”. Ramon Morillofor his part, emphasized the role of SG in the aging of patients living with HIV infection, “This is key to achieving health and well-being and requires creating a connection of care that goes beyond the treatment provided in consultations.”.

Patients’ opinions

Diego Garcia emphasized the importance social determinants related to health (income level, mental health, social/family support, ease of access to socio-medical resources, ease of mobility, access to home care/monitoring) in healthy aging with HIV or any other chronic disease requiring care. “The current situation of many people aging with HIV, with low incomes and a health system that does not make it easy to care for people with difficulties, means that there are large differences in how people age with HIV and in health outcomes.”

– he said.

For his part, Joaquim Roqueta explained that aging with HIV still poses many challenges today. “increased the length and quality of life of people living with HIV. The increase in the aging population with HIV creates chronic age-related conditions due to accelerated aging, heart disease, diabetes, hypertension, and side effects of long-term treatment after ART. may contribute to liver, metabolic and cardiovascular damage.”.

“In Spain, approximately 55% of people with HIV are over 50 years old. Social stigma also affects and can cause isolation. Although current ART regimens are easier to tolerate and less toxic than previous generations of regimens, and significantly improve adhesion.”

Rocket concluded.